🇺🇸
United States · US · US:37662-3335_fda9b1e2-9b93-4782-e053-6394a90ac8d3
Kali Telluricosum
In shortageUNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerHahnemann Laboratories, INC.
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc113766233351200 PELLET in 1 VIAL, GLASS (37662-3335-1)
- ndc1137662333521200 PELLET in 1 BOTTLE, GLASS (37662-3335-2)
- ndc1137662333534000 PELLET in 1 BOTTLE, GLASS (37662-3335-3)
Annotations
UNII (FDA Substance ID)
71M41949N8
POTASSIUM TELLURITE
RxCUI 1921888
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Potassium Chloride Tablet, Extended Release
Raw payload (JSON)
{
"unii": {
"unii": "71M41949N8",
"rxcui": "1921888",
"inchikey": "BFPJYWDBBLZXOM-UHFFFAOYSA-L",
"display_name": "POTASSIUM TELLURITE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"5c6f16fd-d9f4-4601-b2b8-3b67418c1922": {
"match": "brand_token",
"title": "KALI BICHROMICUM 7123 (KALI BICHROMICUM) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]",
"spl_version": "2",
"published_date": "2026-01-12"
}
},
"productid": "37662-3335_fda9b1e2-9b93-4782-e053-6394a90ac8d3",
"productndc": "37662-3335",
"dosage_form": "PELLET",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "POTASSIUM TELLURITE",
"shortage_reason": "Potassium Chloride Tablet, Extended Release",
"shortage_status": "current",
"proprietary_name": "Kali Telluricosum",
"active_ingred_unit": "[hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC",
"nonproprietary_name": "Kali Telluricosum",
"start_marketing_date": "20230608",
"active_numerator_strength": "6"
}Access this data programmatically
Query Kali Telluricosum and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.